Evidence of NTRK1 fusions as resistance mechanism to EGFR TKI in EGFR+ NSCLC. Results from a large-scale survey of NTRK1 fusions in Chinese lung cancer patients
Xia, Hui, Xue, Xingyang, Ding, Huaxin, Ou, Qiuxiang, Wu, Xue, Nakasaga, Misako, Shao, Yang W., Hu, Xingsheng, Ignatius Ou, Sai-HongLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2019.09.004
Date:
September, 2019
File:
PDF, 1.34 MB
english, 2019